ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Letter From The CEO: A New Era Of Drug Development Is Here

  This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.

• Overcoming 5 Challenges Of Implementing eClinical Technologies

  Assess five common pitfalls trial teams face when incorporating new technology and identify potential solutions to mitigate the common risks.

• Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology

  Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.

• Focusing On Patient-Reported Outcome Measures And eConsent

  Learn how digital solutions can contribute to a more participant-centered approach and potentially enhance the regulatory utility of PRO data while improving the overall quality and efficiency of oncology trials.

• 4 Ways Home Visits Support Successful Rare Disease Clinical Trials

  Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.

• Incorrect Clinical Trial Enrollment Is Preventable. A Tale Of Three Case Studies

  See how three clinical trials used centralized eligibility review to accelerate enrollment, eliminate enrollment-based protocol deviations, and keep studies on track, even at a global scale.

• Trends Shaping The Pharmaceutical Industry's Future

  Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.

• Why Your eTMF Needs Role-Based Access

  Discover how role-based access controls can offer a way for clinical teams to answer the tough questions from regulators, investors, and other parties.

• CRF Validation Best Practices: Building Reliable Clinical Trial Databases

  CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.

• Hidden Costs Of Data Cleaning: Build Quality At The Source

  Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.